-
1
-
-
25144470060
-
Current developments in viral DNA vaccines: Shall they solve the unsolved?
-
DOI 10.1002/rmv.467
-
J. Rajcani T. Mosko I. Rezuchova 2005 Current developments in viral DNA vaccines: Shall they solve the unsolved? Rev. Med. Virol. 15 303 325 (Pubitemid 41345365)
-
(2005)
Reviews in Medical Virology
, vol.15
, Issue.5
, pp. 303-325
-
-
Rajcani, J.1
Mosko, T.2
Rezuchova, I.3
-
2
-
-
35348846543
-
DNA vaccines: Recent technological and clinical advances
-
J.B. Ulmer B. Wahren M.A. Liu 2006 DNA vaccines: Recent technological and clinical advances Discov. Med. 6 109 112
-
(2006)
Discov. Med.
, vol.6
, pp. 109-112
-
-
Ulmer, J.B.1
Wahren, B.2
Liu, M.A.3
-
3
-
-
24944494965
-
Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B
-
T. Bamdad M.H. Roostaee M. Sadeghizadeh F. Mahboudi A. Kazemnejad H. Soleimanjahi 2005 Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B Folia Biol. (Praha) 51 109 113 (Pubitemid 41300836)
-
(2005)
Folia Biologica
, vol.51
, Issue.4
, pp. 109-113
-
-
Bamdad, T.1
Roostaee, M.H.2
Sadeghizadeh, M.3
Mahboudi, F.4
Kazemnejad, A.5
Soleimanjahi, H.6
-
4
-
-
0037237569
-
Recent progress in herpes simplex virus immunobiology and vaccine research
-
DOI 10.1128/CMR.16.1.96-113.2003
-
D.M. Koelle L. Corey 2003 Recent progress in herpes simplex virus immunobiology and vaccine research Clin. Microbiol. Rev. 16 96 113 (Pubitemid 36114709)
-
(2003)
Clinical Microbiology Reviews
, vol.16
, Issue.1
, pp. 96-113
-
-
Koelle, D.M.1
Corey, L.2
-
5
-
-
34249741641
-
Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice
-
DOI 10.1016/j.cimid.2007.01.002, PII S0147957107000100
-
A. Ghaemi H. Soleimanjahi T. Bamdad S. Soudi E. Arefeian S.M. Hashemi M. Ebtekar 2007 Induction of humoral and cellular immunity against latent HSV1 infections by DNA immunization in BALB/c mice Comp. Immunol. Microbiol. Infect. Dis. 30 197 210 (Pubitemid 46825174)
-
(2007)
Comparative Immunology, Microbiology and Infectious Diseases
, vol.30
, Issue.4
, pp. 197-210
-
-
Ghaemi, A.1
Soleimanjahi, H.2
Bamdad, T.3
Soudi, S.4
Arefeian, E.5
Hashemi, S.M.6
Ebtekar, M.7
-
6
-
-
0032747388
-
DNA and RNA-based vaccines: Principles, progress, and prospects
-
W.W. Leitner H. Ying N.P. Restifo 1999 DNA and RNA-based vaccines: Principles, progress, and prospects Vaccine 18 765 777
-
(1999)
Vaccine
, vol.18
, pp. 765-777
-
-
Leitner, W.W.1
Ying, H.2
Restifo, N.P.3
-
7
-
-
0031157897
-
Nucleic acid vaccines: An overview
-
DOI 10.1016/S0264-410X(96)00249-6, PII S0264410X96002496
-
H.L. Robinson 1997 Nucleic acid vaccines: An overview Vaccine 15 785 787 (Pubitemid 27287955)
-
(1997)
Vaccine
, vol.15
, Issue.8
, pp. 785-787
-
-
Robinson, H.L.1
-
8
-
-
33846862917
-
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model
-
DOI 10.1016/j.vaccine.2006.10.057, PII S0264410X06011960
-
E. Rollman N. Mathy 2007 Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model Vaccine 25 2145 2154 (Pubitemid 46227663)
-
(2007)
Vaccine
, vol.25
, Issue.11
, pp. 2145-2154
-
-
Rollman, E.1
Mathy, N.2
Brave, A.3
Boberg, A.4
Kjerrstrom, A.5
Van Wely, C.6
Engstrom, G.7
Johansson, S.8
Aperia, K.9
Eriksson, L.E.10
Benthin, R.11
Ertl, P.12
Heeney, J.13
Hinkula, J.14
Voss, G.15
Wahren, B.16
-
9
-
-
33947095436
-
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost
-
DOI 10.1016/j.vaccine.2006.05.081, PII S0264410X06006554
-
J. Liu M. Hellerstein M. [tmp] McDonnel R.R. Amara L.S. Wyatt B. Moss H.L. Robinson 2007 Doseresponse studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost Vaccine 25 2951 2958 (Pubitemid 46412560)
-
(2007)
Vaccine
, vol.25
, Issue.15
, pp. 2951-2958
-
-
Liu, J.1
Hellerstein, M.2
McDonnel, M.3
Amara, R.R.4
Wyatt, L.S.5
Moss, B.6
Robinson, H.L.7
-
11
-
-
0028070714
-
Functional role of type I and type II interferons in antiviral defense
-
U. Muller U. Steinhoff L.F. Reis S. Hemmi J. Pavlovic R.M. Zinkernagel M. Aguet 1994 Functional role of type I and type II interferons in antiviral defense Science 264 1918 1921 (Pubitemid 24245635)
-
(1994)
Science
, vol.264
, Issue.5167
, pp. 1918-1921
-
-
Muller, U.1
Steinhoff, U.2
Reis, L.F.L.3
Hemmi, S.4
Pavlovic, J.5
Zinkernagel, R.M.6
Aguet, M.7
-
13
-
-
0029957972
-
Role of interferon-γ in immunity to herpes simplex virus
-
Z. Yu E. Manickan B.T. Rouse 1996 Role of interferon-gamma in immunity to herpes simplex virus J. Leukoc. Biol. 60 528 532 (Pubitemid 26356779)
-
(1996)
Journal of Leukocyte Biology
, vol.60
, Issue.4
, pp. 528-532
-
-
Yu, Z.1
Manickan, E.2
Rouse, B.T.3
-
14
-
-
23244464478
-
Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression
-
DOI 10.1128/JVI.79.16.10339-10347.2005
-
V. Decman P.R. Kinchington S.A. Harvey R.L. Hendricks 2005 Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression J. Virol. 79 10339 10347 (Pubitemid 41098574)
-
(2005)
Journal of Virology
, vol.79
, Issue.16
, pp. 10339-10347
-
-
Decman, V.1
Kinchington, P.R.2
Harvey, S.A.K.3
Hendricks, R.L.4
-
15
-
-
18644365244
-
+ T cells during primary and secondary viral infections
-
+ T cells during primary and secondary viral infections J. Immunol. 174 5936 5940 (Pubitemid 40663779)
-
(2005)
Journal of Immunology
, vol.174
, Issue.10
, pp. 5936-5940
-
-
Liu, F.1
Whitton, J.L.2
-
16
-
-
33845430956
-
Evaluation of γ-interferon kinetics in HSV-1 infected mice in different days post infection (in vivo) and post re-stimulation (in vitro)
-
DOI 10.1016/j.cimid.2006.09.001, PII S0147957106000567
-
E. Arefian T. Bamdad H. Soleimanjahi F. Sabahi M.R. Akhoond M. Parsania A. Ghaemi 2007 Evaluation of gamma-interferon kinetics in HSV1 infected mice in different days post infection (in vivo) and post re-stimulation (in vitro) Comp. Immunol. Microbiol. Infect. Dis. 30 1 9 (Pubitemid 44890688)
-
(2007)
Comparative Immunology, Microbiology and Infectious Diseases
, vol.30
, Issue.1
, pp. 1-9
-
-
Arefian, E.1
Bamdad, T.2
Soleimanjahi, H.3
Sabahi, F.4
Akhoond, M.R.5
Parsania, M.6
Ghaemi, A.7
-
17
-
-
0034176364
-
The prime-boost strategy: Exciting prospects for improved vaccination
-
DOI 10.1016/S0167-5699(00)01612-1, PII S0167569900016121
-
I.A. Ramshaw A.J. Ramsay 2000 The prime-boost strategy: Exciting prospects for improved vaccination Immunol. Today. 21 163 165 (Pubitemid 30184783)
-
(2000)
Immunology Today
, vol.21
, Issue.4
, pp. 163-165
-
-
Ramshaw, I.A.1
Ramsay, A.J.2
-
18
-
-
20044364936
-
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas
-
DOI 10.1200/JCO.2005.10.206
-
J.L. Marshall J.L. Gulley 2005 Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas J. Clin. Oncol. 23 720 731 (Pubitemid 46224171)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.4
, pp. 720-731
-
-
Marshall, J.L.1
Gulley, J.L.2
Arlen, P.M.3
Beetham, P.K.4
Tsang, K.-Y.5
Slack, R.6
Hodge, J.W.7
Doren, S.8
Grosenbach, D.W.9
Hwang, J.10
Fox, E.11
Odogwu, L.12
Park, S.13
Panicali, D.14
Schlom, J.15
-
19
-
-
0033948976
-
Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: A phase I/II clinical trial
-
M. Mincheff S. Tchakarov S. Zoubak D. Loukinov C. Botev I. Altankova G. Georgiev S. Petrov H.T. Meryman 2000 Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: A phase I/II clinical trial Eur. Urol. 38 208 217 (Pubitemid 30452325)
-
(2000)
European Urology
, vol.38
, Issue.2
, pp. 208-217
-
-
Mincheff, M.1
Tchakarov, S.2
Zoubak, S.3
Loukinov, D.4
Botev, C.5
Altankova, I.6
Georgiev, G.7
Petrov, S.8
Meryman, H.T.9
-
20
-
-
33646841500
-
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis
-
DOI 10.1016/j.vaccine.2005.08.048, PII S0264410X05008182
-
S.C. Gilbert V.S. Moorthy 2006 Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis Vaccine 24 4554 4561 (Pubitemid 43776762)
-
(2006)
Vaccine
, vol.24
, Issue.21
, pp. 4554-4561
-
-
Gilbert, S.C.1
Moorthy, V.S.2
Andrews, L.3
Pathan, A.A.4
McConkey, S.J.5
Vuola, J.M.6
Keating, S.M.7
Berthoud, T.8
Webster, D.9
McShane, H.10
Hill, A.V.S.11
-
21
-
-
0033607187
-
BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1
-
DOI 10.1073/pnas.96.22.12697
-
M. Suter A.M. Lew P. Grob G.J. Adema M. Ackermann K. Shortman C. Fraefel 1999 BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, pack-aging-defective virus genome induces protective immunity against herpes simplex virus 1 Proc. Natl. Acad. Sci. USA. 96 12697 12702 (Pubitemid 29513565)
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, Issue.22
, pp. 12697-12702
-
-
Suter, M.1
Lew, A.M.2
Grob, P.3
Adema, G.J.4
Ackermann, M.5
Shortman, K.6
Fraefel, C.7
-
22
-
-
21844456012
-
The duration of in vitro stimulation with recall antigens determines the subset distribution of interferon-γ-producing lymphoid cells: A kinetic analysis using the Interferon-γ Secretion Assay™
-
DOI 10.1016/j.jim.2005.04.008, PII S0022175905001158
-
I. Desombere F. Clement H. Rigole G. Leroux-Roels 2005 The duration of in vitro stimulation with recall antigens determines the subset distribution of interferon-gamma-producing lymphoid cells: A kinetic analysis using the interferon-gamma secretion assay J. Immunol. Methods. 301 124 139 (Pubitemid 40961980)
-
(2005)
Journal of Immunological Methods
, vol.301
, Issue.1-2
, pp. 124-139
-
-
Desombere, I.1
Clement, F.2
Rigole, H.3
Leroux-Roels, G.4
|